Front Line Genomics invites you to their event

Hereditary cancer: Taking on tomorrow with powerful insights

About this event

Next generation sequencing (NGS) is a powerful tool for uncovering a patient’s inherited susceptibility to cancer, paving the way for more effective prevention strategies. However, hereditary cancer testing can pose significant challenges to clinical labs, including the pace of evolution guidelines, laborious detection of complex variants, and fragments workflows.

In this webinar, we will demonstrate how to better handle the complexity of NGS data analysis and variant interpretation, so that you can confidently assess genetic variants predisposing to cancer. We will present clinical researchers with enhanced tools for hereditary cancer research, exploring real-life application examples from two major European cancer institutes.

Matteo Dal Molin, from the European Institute of Oncology in Milan, Italy, will present his institute’s experience using the SOPHiA DDM™ Hereditary Cancer Solution in clinical research, and present insights on why this solution is the ultimate NGS application for characterizing genetic variants predisposing to cancer.

---

From this webinar, you will:

- Gain insights into the analytical performance results of a study conducted in collaboration with a UK hospital, based on a set of challenging clinical samples.

- Learn from the implementation of a hereditary cancer solution in clinical research, from the European Institute of Oncology.

- Find out more about the guidelines driven content, enhanced features and streamlined workflow of a capture-base application, SOPHIA DDM™ Hereditary Cancer Solution (HCS) v2.0.

- Discover improved analytical capabilities for detection of copy number variants (CNVs), Alu insertions, Boland insertions and PMS2/PMS2CL gene conversion.

- Discover new applications that accelerate germline mutation testing and analysis for diverse cancer types, to empower you with a comprehensive view of complex variants.

---

Speakers:


Matteo Dal Molin, Medical Genetics Lab, European Institute of Oncology, Milan, Italy



Sevana Yabhoubian, Senior Director Genomics, SOPHiA GENETICS



Tamara Maas, Senior Director Bioinformatics, SOPHiA GENETICS



----

This webinar has been produced with the kind support of SOPHiA GENETICS. You can find out more about the technologies outlined in this webinar by visiting the SOPHiA GENETICS website.

Hosted by

  • Guest speaker
    MD G
    Matteo Dal Molin

  • Guest speaker
    SY G
    Sevana Yabhoubian

  • Guest speaker
    ML G
    Marinela Leka

  • Guest speaker
    TM G
    Tamara Maas

  • Team member
    Od T
    Ollie de Jong Front Line Genomics

Front Line Genomics

Delivering the Benefits of Genomics to Patients Faster

Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.